← SynDRA
RETAPAMULIN
SynDRA canonical compound SYN0016493 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | protein synthesis inhibitor |
|---|
| Indication | impetigo |
|---|
| Disease area | infectious disease |
|---|
Mechanisms of action (all sources)
- protein synthesis inhibitor
Drug classes
- Pleuromutilin Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- D06A · ANTIBIOTICS FOR TOPICAL USE
Cross-references
Synonyms
- altabax
- altargo
- mutilin
- retpamulin
- SB275833
- SB-275833
- Retapamuline
- Retapamulina
- NSC-759885
- Altabax
- Altargo
- SB 275833
- Altabax (Glaxo)
- Altabax (TN)
- Altargo (TN)
- Retapamulin (USAN/INN)
- C30H47NO4S
- 4MG6O8991R
- MFCD11045316
- NSC 759885
- retapamuline
- Ritamorin
- UNII-4MG6O8991R
- Retapamulin [USAN:INN:BAN]
- Altabax;
- RETAPAMULIN [MI]
- RETAPAMULIN [INN]
- RETAPAMULIN [USAN]
- RETAPAMULIN [VANDF]
- RETAPAMULIN [MART.]
- RETAPAMULIN [WHO-DD]
- SCHEMBL365459
- RETAPAMULIN [EMA EPAR]
- SCHEMBL23977320
- SCHEMBL30479719
- GTPL11035
- RETAPAMULIN [ORANGE BOOK]
- CHEBI:166679
Reported adverse events
- Pruritus
- Application site irritation
- Application site pain
- Application site pruritus
- Eczema
- Headache
- Nasopharyngitis
- Nausea
- Pyrexia
Look up RETAPAMULIN in the interactive SynDRA portal →